Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
argenx SE - American Depositary Shares
(NQ:
ARGX
)
859.91
+0.48 (+0.06%)
Streaming Delayed Price
Updated: 12:06 PM EDT, Jul 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
90,158
Open
860.67
Bid (Size)
858.21 (120)
Ask (Size)
862.36 (80)
Prev. Close
859.43
Today's Range
854.17 - 866.72
52wk Range
554.59 - 953.58
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
argenx to Host Autoimmune Myositis R&D Webinar
June 23, 2026
From
argenx SE
Via
GlobeNewswire
argenx Eyes More VYVGART Growth as Pipeline Catalysts Near
↗
June 12, 2026
Executives at argenex (NASDAQ:ARGX) told investors at a Goldman Sachs healthcare event that they continue to see meaningful growth opportunities for VYVGART across myasthenia gravis and chronic...
Via
MarketBeat
Topics
Intellectual Property
Supply Chain
Performance
YTD
+2.4%
+2.4%
1 Month
-2.7%
-2.7%
3 Month
+3.8%
+3.8%
6 Month
+6.1%
+6.1%
1 Year
+53.2%
+53.2%
More News
Read More
argenx Touts VYVGART Growth, 50,000-Patient Goal at William Blair Conference
↗
June 05, 2026
Via
MarketBeat
Topics
Intellectual Property
argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026
June 03, 2026
From
argenx SE
Via
GlobeNewswire
Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800%
↗
May 29, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More
↗
May 29, 2026
Via
The Motley Fool
argenx to Host Myositis R&D Webinar on June 23, 2026
May 28, 2026
From
argenx SE
Via
GlobeNewswire
argenx to Present at Upcoming Investor Conferences
May 27, 2026
From
argenx SE
Via
GlobeNewswire
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares
↗
May 16, 2026
Via
The Motley Fool
2 Ways to Play the Big Pharma Patent Cliff
↗
May 15, 2026
Via
MarketBeat
Topics
ETFs
Intellectual Property
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
May 08, 2026
From
argenx SE
Via
GlobeNewswire
argenx Reports First Quarter 2026 Financial Results and Provides Business Update
May 07, 2026
From
argenx SE
Via
GlobeNewswire
argenx to Present at BofA Securities 2026 Health Care Conference
May 06, 2026
From
argenx SE
Via
GlobeNewswire
argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer
May 06, 2026
From
argenx SE
Via
GlobeNewswire
argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
April 30, 2026
From
argenx SE
Via
GlobeNewswire
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
April 18, 2026
From
argenx SE
Via
GlobeNewswire
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
↗
March 21, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch
↗
March 21, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
argenx announces Annual General Meeting of Shareholders on May 6, 2026
March 20, 2026
From
argenx SE
Via
GlobeNewswire
This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund
↗
March 20, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Complementing the Future: A Deep Dive into Dianthus Therapeutics (DNTH) After Its Phase 3 Breakthrough
March 12, 2026
Via
Finterra
Topics
Economy
DNTH Stock Soars After Early ‘Go’ Decision For Drug In Autoimmune Disorder Program, Boosting Wall Street Optimism For Potential Launch
↗
March 09, 2026
Via
Stocktwits
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
March 06, 2026
From
argenx SE
Via
GlobeNewswire
Argenx (ARGX) 2026 Feature: The Anatomy of a Biotech Powerhouse Transitioning to Profitability
February 26, 2026
Via
Finterra
Topics
Earnings
Economy
Intellectual Property
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
February 26, 2026
From
argenx SE
Via
GlobeNewswire
Frequently Asked Questions
Is argenx SE - American Depositary Shares publicly traded?
Yes, argenx SE - American Depositary Shares is publicly traded.
What exchange does argenx SE - American Depositary Shares trade on?
argenx SE - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for argenx SE - American Depositary Shares?
The ticker symbol for argenx SE - American Depositary Shares is ARGX on the Nasdaq Stock Market
What is the current price of argenx SE - American Depositary Shares?
The current price of argenx SE - American Depositary Shares is 859.91
When was argenx SE - American Depositary Shares last traded?
The last trade of argenx SE - American Depositary Shares was at 07/15/26 12:06 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
